ProfileGDS4718 / 202545_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 91% 71% 92% 89% 79% 70% 90% 91% 90% 90% 91% 82% 79% 78% 85% 88% 83% 79% 70% 91% 90% 91% 91% 90% 85% 90% 81% 92% 75% 84% 74% 92% 93% 75% 73% 83% 87% 92% 61% 92% 83% 80% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.3130290
GSM549102patient 115, normal, homogenized [OPG study]9.2676291
GSM549104patient 119, normal, homogenized [OPG study]6.9714671
GSM549108patient 138, normal, homogenized [OPG study]9.4632892
GSM549119patient 077, normal, homogenized [OPG study]9.0962189
GSM549133patient 032, cancer, homogenized [OPG study]7.8281679
GSM549139patient 042, cancer, homogenized [OPG study]6.8817770
GSM549099patient 107, normal, homogenized [OPG study]9.0923490
GSM549109patient 139, normal, homogenized [OPG study]9.3718491
GSM549110patient 046, normal, homogenized [OPG study]9.271990
GSM549114patient 063, normal, homogenized [OPG study]9.3652590
GSM549122patient 082, normal, homogenized [OPG study]9.4635791
GSM549134patient 033, cancer, homogenized [OPG study]8.0974582
GSM549136patient 036, cancer, homogenized [OPG study]7.8943779
GSM549140patient 044, cancer, homogenized [OPG study]7.7066678
GSM549111patient 047, normal, homogenized [OPG study]8.4856285
GSM549113patient 057, normal, homogenized [OPG study]9.0962188
GSM549132patient 031, cancer, homogenized [OPG study]8.1666183
GSM549137patient 038, cancer, homogenized [OPG study]7.8357679
GSM549142patient 047, cancer, homogenized [OPG study]6.8238370
GSM549100patient 110, normal, homogenized [OPG study]9.4161391
GSM549107patient 135, normal, homogenized [OPG study]9.1940990
GSM549115patient 068, normal, homogenized [OPG study]9.550591
GSM549116patient 072, normal, homogenized [OPG study]9.4229791
GSM549120patient 078, normal, homogenized [OPG study]9.3068890
GSM549131patient 030, cancer, homogenized [OPG study]8.5356785
GSM549118patient 074, normal, homogenized [OPG study]9.30690
GSM549129patient 027, cancer, homogenized [OPG study]7.9513381
GSM549123patient 088, normal, homogenized [OPG study]9.5652192
GSM549124patient 006, cancer, homogenized [OPG study]7.2803875
GSM549126patient 015, cancer, homogenized [OPG study]8.2848184
GSM549128patient 025, cancer, homogenized [OPG study]7.3461774
GSM549103patient 117, normal, homogenized [OPG study]9.3997892
GSM549117patient 073, normal, homogenized [OPG study]9.8486193
GSM549138patient 041, cancer, homogenized [OPG study]7.3445375
GSM549141patient 045, cancer, homogenized [OPG study]7.2498573
GSM549130patient 028, cancer, homogenized [OPG study]8.1771283
GSM549101patient 111, normal, homogenized [OPG study]8.7352887
GSM549105patient 128, normal, homogenized [OPG study]9.4764392
GSM549106patient 134, normal, homogenized [OPG study]6.1873561
GSM549112patient 048, normal, homogenized [OPG study]9.548892
GSM549125patient 011, cancer, homogenized [OPG study]8.1801983
GSM549127patient 024, cancer, homogenized [OPG study]7.9412380
GSM549135patient 035, cancer, homogenized [OPG study]7.8606879